A detailed history of Susquehanna International Group, LLP transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 176,105 shares of ASRT stock, worth $165,538. This represents 0.0% of its overall portfolio holdings.

Number of Shares
176,105
Previous 490,257 64.08%
Holding current value
$165,538
Previous $607,000 65.9%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.07 - $1.75 $336,142 - $549,766
-314,152 Reduced 64.08%
176,105 $207,000
Q2 2024

Aug 15, 2024

BUY
$0.75 - $1.31 $266,109 - $464,805
354,813 Added 261.96%
490,257 $607,000
Q1 2024

May 07, 2024

BUY
$0.79 - $1.14 $18,083 - $26,094
22,890 Added 20.34%
135,444 $130,000
Q4 2023

Feb 14, 2024

SELL
$1.02 - $2.57 $26,360 - $66,419
-25,844 Reduced 18.67%
112,554 $120,000
Q3 2023

Nov 14, 2023

SELL
$2.52 - $5.69 $347,991 - $785,743
-138,092 Reduced 49.94%
138,398 $354,000
Q2 2023

Aug 11, 2023

SELL
$5.0 - $7.66 $274,035 - $419,821
-54,807 Reduced 16.54%
276,490 $1.5 Million
Q1 2023

May 16, 2023

BUY
$3.54 - $6.66 $1.17 Million - $2.21 Million
331,297 New
331,297 $2.11 Million
Q3 2022

Nov 14, 2022

BUY
$2.13 - $4.0 $37,505 - $70,432
17,608 Added 36.1%
66,379 $151,000
Q2 2022

Aug 15, 2022

SELL
$1.88 - $3.42 $6,946 - $12,636
-3,695 Reduced 7.04%
48,771 $144,000
Q1 2022

May 16, 2022

BUY
$2.06 - $3.0 $4,496 - $6,549
2,183 Added 4.34%
52,466 $151,000
Q4 2021

Feb 14, 2022

BUY
$0.86 - $2.3 $5,777 - $15,451
6,718 Added 15.42%
50,283 $110,000
Q3 2021

Nov 15, 2021

BUY
$0.89 - $1.55 $38,772 - $67,525
43,565 New
43,565 $39,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $45.3M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.